We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+10.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$6.71B
AUM Growth
+$2.5B
(+59%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
30.61%
Top 10 Holdings %
Top 10 Hldgs %
14.85%
Holding
2,565
New
44
Increased
937
Reduced
347
Closed
1,235
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$92.8M |
| 2 |
Microsoft
MSFT
|
+$58.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$56.5M |
| 4 |
ExxonMobil
XOM
|
+$46.3M |
| 5 |
Chevron
CVX
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$4.89M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$3.48M |
| 3 |
NYX
NYSE EURONEXT INC
NYX
|
+$3.27M |
| 4 |
CoStar Group
CSGP
|
+$2.8M |
| 5 |
VPHM
VIROPHARMA INC
VPHM
|
+$2.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.32% |
| 2 | Technology | 15.24% |
| 3 | Healthcare | 12.35% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMH
1126
DELISTED
Team Health Holdings Inc
TMH
| $337K | 0.01% |
7,391
-37,822
| -84% | -$1.68M |
|
|
CPHD
1127
DELISTED
Cepheid Inc
CPHD
| $337K | 0.01% |
7,207
-36,950
| -84% | -$1.57M |
|
|
HITT
1128
DELISTED
HITTITE MICROWAVE CORP
HITT
| $337K | 0.01% |
5,466
-17,350
| -76% | -$1.09M |
|
1129
Erie Indemnity
ERIE
$11.7B
| $334K | 0.01% |
4,574
-40
| -0.9% | -$2.85K |
|
|
ANAC
1130
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $332K | ﹤0.01% |
19,759
-10,512
| -35% | -$145K |
|
1131
Herc Holdings
HRI
$5.43B
| $329K | ﹤0.01% |
3,832
-52
| -1% | -$3.71K |
|
1132
Teledyne Technologies
TDY
$30.4B
| $328K | ﹤0.01% |
3,573
-21,214
| -86% | -$1.89M |
|
|
SWC
1133
DELISTED
Stillwater Mining Co
SWC
| $328K | ﹤0.01% |
26,613
-58,193
| -69% | -$656K |
|
|
MRH
1134
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
| $327K | ﹤0.01% |
11,227
-25,285
| -69% | -$705K |
|
|
AFFX
1135
DELISTED
Affymetrix Inc
AFFX
| $323K | ﹤0.01% |
37,744
-34,096
| -47% | -$261K |
|
1136
Neurocrine Biosciences
NBIX
$17.7B
| $322K | ﹤0.01% |
34,527
-31,180
| -47% | -$304K |
|
1137
New Jersey Resources
NJR
$6.06B
| $322K | ﹤0.01% |
13,926
-49,066
| -78% | -$1.1M |
|
|
ARGO
1138
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $322K | ﹤0.01% |
9,639
-21,259
| -69% | -$678K |
|
1139
EnerSys
ENS
$6.95B
| $321K | ﹤0.01% |
4,584
-27,314
| -86% | -$1.83M |
|
1140
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $321K | ﹤0.01% |
+3,454
| New | +$321K |
|
1141
HEICO Corp
HEI
$48.9B
| $318K | ﹤0.01% |
13,389
-89,974
| -87% | -$2.03M |
|
|
ARRY
1142
DELISTED
Array Biopharma Inc
ARRY
| $318K | ﹤0.01% |
63,499
-51,367
| -45% | -$280K |
|
1143
Geron
GERN
$911M
| $316K | ﹤0.01% |
70,504
-64,945
| -48% | -$279K |
|
|
XOMA
1144
DELISTED
Xoma
XOMA
| $314K | ﹤0.01% |
2,331
-1,473
| -39% | -$148K |
|
1145
Encompass Health
EHC
$11.2B
| $313K | ﹤0.01% |
11,791
-60,402
| -84% | -$1.68M |
|
1146
TD Synnex
SNX
$19.4B
| $310K | ﹤0.01% |
9,198
-31,430
| -77% | -$1,000K |
|
|
ASRT
1147
DELISTED
Assertio
ASRT
| $309K | ﹤0.01% |
487
-440
| -47% | -$215K |
|
1148
Cognex
CGNX
$10.3B
| $309K | ﹤0.01% |
16,170
-98,450
| -86% | -$1.6M |
|
1149
MBIA
MBI
$288M
| $309K | ﹤0.01% |
25,913
-424
| -2% | -$4.88K |
|
1150
Avista
AVA
$3.47B
| $306K | ﹤0.01% |
10,848
-35,481
| -77% | -$973K |
|
Similar funds
ProShare Advisors's Q4 2013 Portfolio in Review
As of Q4 2013, ProShare Advisors held 2,565 positions worth $6.71B, up 59% from $4.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
ProShare Advisors deployed $2.05B of net new capital in Q4 2013, opening 44 new positions and adding to 937 existing holdings. Its largest new stake was VEON: 13,524 shares worth $4.38M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was CoStar Group, an estimated $2.8M trimmed.
- ProShare Advisors's largest Q4 2013 buy was VEON: 13,524 shares worth $4.38M.
- ProShare Advisors added most to Apple in Q4 2013, an estimated $92.8M increase.
- ProShare Advisors's biggest Q4 2013 reduction was CoStar Group, cutting an estimated $2.8M.
- ProShare Advisors fully exited DELL INC in Q4 2013, selling an estimated $4.89M.
- ProShare Advisors's ten largest holdings make up 15% of its $6.71B portfolio in Q4 2013.
- ProShare Advisors opened 44 new positions and closed 1,235 in Q4 2013.
- ProShare Advisors's portfolio value rose 59% quarter-over-quarter to $6.71B.
Based on ProShare Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.